Australia has a vibrant medical technology and pharmaceutical (MTP) sector, recognised globally for its excellence and innovation. With nearly 1,300 companies and an exceptionally skilled workforce of 68,000 across industry and research, the MTP sector is a major contributor to the Australian economy. Dr Rebecca Tunstall, Senior Director of Stakeholder Engagement at MTPConnect, leads collaborative teams to drive connectivity, innovation and productivity in this sector. Rebecca outlined emerging “megatrends” that will ‘reshape our world in the next 10-50 years.’ Digital evolution is central to them all, allowing the rapid exchange of information, advances in genomic sequencing and big data collection to support precision medicine, and integrated care models with artificial intelligence and robotics. She wants to see Australia at the forefront, revolutionising healthcare with these emerging technologies.